Foscarbidopa

Overview

Foscarbidopa (ABBV-951; Carbidopa 4′-monophosphate) is an inhibitory prodrug targeting peripheral aromatic L-amino acid decarboxylase . Foscarbidopa is hydrolyzed into Carbidopa ( HY-B0311 ) by phosphatases in vivo to suppress peripheral metabolism of levodopa and elevate brain delivery of levodopa. Foscarbidopa can be used for the research of Parkinson’s disease and advanced Parkinson’s disease.

Application

Products | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Neurodegenerative Disease | Products > Disease Areas > Parkinson's Disease | Products > Signaling Pathways > Immunology/Inflammation | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Neurological Disease | Products > Signaling Pathways > Aryl Hydrocarbon Receptor | Products > Signaling Pathways > Drug Metabolite

Product Information

• Catalog No.: HY-109131
• CAS No.: 1907685-81-7
• Molecular Formula: C10H15N2O7P
• Molecular Weight: 306.21
• Purity: 95.91%
• Storage: Powder -20°C, 3 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Availability: In-stock

Source

Original product source